NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1629649
MILWAUKEE, WI
Position in NBIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,812,037
+$850,127 QoQ
Shares Held
22,618
+0.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#242
of 768 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC holds $16,586,622 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (23.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
9,548 | $5,173,392 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
22,618 | $3,812,037 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
112,349 | $2,764,908 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
47,672 | $1,652,788 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
14,645 | $1,624,716 | |
| 6 | ZTS |
Zoetis Inc.
|
13,441 | $965,870 | |
| 7 | VTRS |
Viatris Inc
|
37,337 | $592,911 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,812,037 | 22,618 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,961,910 | 22,483 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,163,943 | 22,308 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $3,103,380 | 22,107 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $2,777,371 | 22,097 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,451,891 | 22,169 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,071,523 | 22,502 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,581,273 | 22,403 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,092,343 | 22,462 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $3,061,134 | 22,195 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,880,010 | 21,858 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,436,525 | 21,658 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,044,895 | 21,685 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,169,043 | 21,429 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,062,657 | 8,897 | Shares | Defined | 2023-02-21 | |
| 2022-09-30 | $1,466,972 | 13,812 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,559,485 | 15,998 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $1,477,125 | 15,756 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $1,339,383 | 15,726 | Shares | Defined | 2022-02-03 | |
| 2021-09-30 | $1,499,552 | 15,635 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,532,400 | 15,746 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,518,072 | 15,610 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||